Antimicrobial resistance is a major public health issue across the globe. On September 4, 2019, we lost a partner in that mission. Stuart Levy, MD, one of the earliest and loudest voices warning of the dangers of antibiotic overuse in both humans and animals, passed away after a prolonged illness.
Find your way through a scenario involving an infection leading to sepsis. At critical points, you must make choices about what you would do—and just like in real life, the decisions you make can change your ultimate outcome.
During our September 12, 2019 webinar, titled, “New Technology and Workflow Optimization in the Microbiology Lab: Working Together to Improve Patient Care,” Dr. Allison McMullen, Ph.D., D(ABMM), will share how microbiology is meeting today’s clinical challenges in the context of Antimicrobial Stewardship Programs (ASPs).
Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.